Finance

Lists
300147:SHE
Xiangxue Pharmaceutical Co Ltd
5,14 CN¥
-1,34%
(-0,070) 1D
16 հոկ, 15:04:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300147...
Open
5,11 CN¥
High
5,30 CN¥
Low
5,10 CN¥
Mkt. cap
3,40 մլրդ
Avg. vol.
10,62 մլն
Volume
8,21 մլն
52-wk high
11,23 CN¥
52-wk low
5,03 CN¥
EPS
-2,16 CN¥
Shares outstanding
661,28 մլն
No. of employees
3 հզր
Open
5,11 CN¥
High
5,30 CN¥
Low
5,10 CN¥
Mkt. cap
3,40 մլրդ
Avg. vol.
10,62 մլն
Volume
8,21 մլն
52-wk high
11,23 CN¥
52-wk low
5,03 CN¥
EPS
-2,16 CN¥
Shares outstanding
661,28 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
Profile
Xiangxue Pharmaceutical Co., Ltd. also known as XPH, is a Chinese pharmaceutical company. It was headquartered in Guangzhou Economic and Technological Development Zone, Guangzhou, the capital of the Guangdong Province. The company started in a place that near to the tourist spot Luogang Xiangxue, thus called itself Xiangxue. Xiangxue Pharmaceutical was a constituent of SZSE 200 Index, but was removed in January 2017; it was inserted to SZSE 700 Index instead at the same time. SZSE 200, 300 and 700 Indexes are subsets of SZSE 1000 Index, the latter is a stock market index for the top 1,000 companies by free-float adjusted capitalization. In July 2017 Xiangxue was also removed from SZSE Component Index, an index for top 500 companies of the exchange. Wikipedia
About Xiangxue Pharmaceutical Co Ltd
CEO-
Employees2,66 հզր
Founded29 դեկ, 1997 թ.
Headquarters-
Sector-
Websitexphcn.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
327,92 մլն
449,49 մլն
354,16 մլն
348,62 մլն
Cost of goods sold
176,35 մլն
388,48 մլն
228,49 մլն
252,20 մլն
Cost of revenue
176,35 մլն
388,48 մլն
228,49 մլն
252,20 մլն
Research and development expenses
15,40 մլն
22,13 մլն
10,74 մլն
11,51 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
132,20 մլն
75,98 մլն
89,74 մլն
95,27 մլն
Operating expense
153,13 մլն
108,42 մլն
97,82 մլն
111,19 մլն
Total operating expenses
329,48 մլն
496,91 մլն
326,31 մլն
363,40 մլն
Operating income
-1,56 մլն
-47,41 մլն
27,85 մլն
-14,78 մլն
Other non operating income
302,00 հզր
-14,25 մլն
-944,82 հզր
-2,74 մլն
EBT including unusual items
-118,29 մլն
-1,00 մլրդ
-89,20 մլն
-147,88 մլն
EBT excluding unusual items
-67,96 մլն
-144,93 մլն
-40,82 մլն
-81,08 մլն
Income tax expense
3,13 մլն
30,08 մլն
9,14 մլն
5,48 մլն
Effective tax rate
-2,65%
-3,00%
-10,25%
-3,70%
Other operating expenses
3,55 մլն
4,05 մլն
-3,18 մլն
-1,15 մլն
Net income
-128,03 մլն
-1,03 մլրդ
-111,44 մլն
-157,38 մլն
Net profit margin
-39,04%
-229,21%
-31,47%
-45,14%
Earnings per share
-
-
-
-
Interest and investment income
-
175,82 հզր
23,18 հզր
15,53 հզր
Interest expense
-66,70 մլն
-83,47 մլն
-67,75 մլն
-63,58 մլն
Net interest expenses
-66,70 մլն
-83,30 մլն
-67,73 մլն
-63,56 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
52,99 մլն
15,22 հզր
75,28 մլն
37,21 մլն
Gain or loss from assets sale
932,06 հզր
-8,92 մլն
-
-107,04 հզր
AI content may include mistakes. Learn more
Google Apps